What is OncoLens?
OncoLens operates at the intersection of artificial intelligence and digital healthcare, providing a comprehensive multidisciplinary care solution tailored for oncology. The platform is a critical tool for over 10% of U.S. cancer centers and 50% of top pharmaceutical companies, facilitating enhanced patient outcomes via coordinated data analysis and clinical decision support. With an extensive network encompassing more than 5 million oncology patients and 45,000 multidisciplinary physicians, OncoLens is instrumental in improving trial matching, biomarker testing, and overall precision in cancer care. Its services are designed to empower both healthcare providers and life sciences organizations, driving innovation in a rapidly evolving field.
How much funding has OncoLens raised?
OncoLens has raised a total of $27.1M across 4 funding rounds:
Angel/Seed
$1.4M
Private Equity
$2.5M
Series A
$7.3M
Series B
$16M
Angel/Seed (2019): $1.4M, investors not publicly disclosed
Private Equity (2020): $2.5M led by Robbins Fund, Atlanta Technology Angels, and BIP Capital
Series A (2021): $7.3M supported by BIP Capital and Martin Ventures
Series B (2024): $16M featuring BIP Capital, SeedtoB Capital, Martin Ventures, and Cross-Border Impact Ventures
Key Investors in OncoLens
BIP Capital
BIP Capital is a vertically-integrated investment firm that specializes in private equity and credit investment strategies aimed at supporting wealth advisors and their clients. The firm offers direct access to high-quality private equity, venture capital, and private credit products, designed to generate strong performance and competitive advantages.
SeedtoB Capital
SeedtoB Capital is an investment firm focused on supporting healthcare AI startups, particularly those in the Seed and Series A stages, to navigate their path to Series B funding. Founded by innovators from Jvion, the largest prescriptive AI company in healthcare, they leverage their extensive network and expertise to assist entrepreneurs in overcoming challenges.
Martin Ventures
Martin Ventures is a firm that invests in innovative healthcare companies, focusing on transforming the healthcare ecosystem to reward providers for achieving excellent health outcomes. They partner with primary care practices and health systems to facilitate the transition from fee-for-service to value-based care, enhancing patient experiences.
What's next for OncoLens?
The recent major strategic investment in OncoLens signals a strong trajectory for growth and expansion within the competitive digital healthcare and oncology sectors. This capital infusion is expected to fuel further development of its AI-driven platform, enhance its market penetration among healthcare providers and pharmaceutical companies, and potentially broaden its reach into new therapeutic areas or geographical markets. The company's focus on improving patient outcomes and streamlining complex care pathways positions it for continued success and leadership in precision oncology, likely leading to further strategic partnerships and advancements in clinical decision support technologies.
See full OncoLens company page
